INDIANAPOLIS, November 5, 2018 – Trulicity® (dulaglutide) significantly reduced major adverse cardiovascular events (MACE), a composite endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke, meeting the primary efficacy objective in the precedent-setting REWIND trial.

CMS Administrator Seema Verma’s Halloween tweet has drawn lots of attention, including from a government watchdog that says she likely violated the Hatch Act.

Ridgefield, Conn. and Indianapolis, November 5, 2018 — Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study showed Jardiance® was associated with a 44 percent relative risk reduction in hospitalization for heart failure (HHF) compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in routine clinical practice in the U.S.

Clinical reporting strategies for PET/CT imaging exams in the oncology setting vary widely, according to results of a worldwide survey of clinicians published in the Journal of Nuclear Medicine. Thirty percent of respondents reported they were unaware reporting guidelines existed.

Charges will be filed against ward boy Vitthal Chavan of Nair Hospital in Mumbai, India, for his involvement in the death of 32-year-old Rajesh Maru, who walked into an MRI room with a gas cylinder in January.

Biopharmaceutical company Amarin announced top-line results for its purified eicosapentaenoic acid (EPA) product in September, hailing the 25 percent risk reduction in a composite of cardiovascular outcomes associated with icosapent ethyl (Vascepa). But critics who commented on the results to Kaiser Health News worried the excitement over the trial is premature.

Artificial intelligence (AI) can help predict how a breast tumor will respond to neoadjuvant chemotherapy (NAC), according to new findings published in the Journal of Digital Imaging.

Artificial intelligence (AI) is changing the way healthcare providers care for elderly patients through a variety of new AI-powered solutions. One tool that’s making a big splash in the field is the robotic helper, according to a report by Forbes.

“This system has made everything much more transparent in that we can see everyone in every area of the hospital and it makes every area much more transparent because we can see what’s happening,” interventional radiologist Ellen Francesconi, MD, told HealthImaging.

Automated cardiac valve tracking halved the analysis time and variability in blood-flow quantification with four-dimensional (4D) flow MRI, researchers reported in Radiology. The algorithm may help clinicians more efficiently assess the severity of congenital and valvular heart disease, they said.